---
url: https://simplify.jobs/p/4ad1ef54-6517-4d3a-a6ab-ce273afda759/Vice-President--Business-Development
title: "Vice President – Business Development @ Chai Discovery | Simplify Jobs"
clipped: 2026-01-24 15:12
source: browser-history
---

# Vice President – Business Development @ Chai Discovery | Simplify Jobs

> Source: [https://simplify.jobs/p/4ad1ef54-6517-4d3a-a6ab-ce273afda759/Vice-President--Business-Development](https://simplify.jobs/p/4ad1ef54-6517-4d3a-a6ab-ce273afda759/Vice-President--Business-Development)

OverviewCompany

Save

Apply

Full-Time

Open user menu

# Vice President – Business Development

[![Chai Discovery](https://storage.googleapis.com/simplify-imgs/companies/4b69743d-46e7-4986-9c4f-f6e6f6a52c6b/logo.png)](/c/Chai-Discovery)

## Chai Discovery

11-50 employees

AI models predicting molecular structures

No salary listed

San Francisco, CA, USA

In Person

Category

| Business & Strategy (1) |
| --- |
| Business Development |

![logo](/cdn-cgi/image/width=32/images/logos/plus-dark.svg)

Get referrals →

You have ways to **get a Chai Discovery referral** from your network.

![](https://assets.simplify.jobs/emojis/bulb.png)

Applications through a referral are 3x more likely to get an interview!

* Summary
* Full Job Posting

Requirements

* Execution-focused deal operator with legal grounding (JD preferred) and experience drafting, reviewing, and driving complex contracts forward.
* Background in biotech/pharma, or alternatively in startups/technology companies handling complex enterprise deals involving sensitive intellectual property, software, AI models, or regulated data.
* Experience in a law firm supporting biotech, pharma, or regulated technology clients is also highly relevant.
* Demonstrated ability to run multi-step deals end-to-end, managing many simultaneous conversations, legal processes, and cross-functional threads.
* Detail-oriented and intellectually sharp, with strong judgment and the ability to spot risks, implications, and structural issues early.
* Hungry, thoughtful, and highly reliable, someone who founders and executives can trust with day-to-day deal mechanics.
* Track record of operating effectively in lean, founder-led, high-growth environments.

Responsibilities

* Cultivate, manage, and push each deal forward. Lead negotiation of business points and translate the company’s business model and pricing strategy into clear, actionable deal structures. Serve as the operational lead managing all timelines, workflows, and cross-functional threads required to keep deals moving forward.
* Participate in the creation and management of “deal maps”, outlining each partnership’s path, key decision points, gatekeepers, and anticipated interpersonal, political, and business dynamics.
* Own the full contracting workflow, including drafting cycles, redlines, internal reviews, and coordination with external counsel, while maintaining momentum across all legal components of each deal, ensuring strategic partnerships progress smoothly from initial discussion through close.
* Help define and maintain the IP strategy supporting partnerships.
* Oversee contracts beyond partnerships, including CRO agreements and data-generation partners.

Desired Qualifications

* Highly motivated by impact, responsibility, and the opportunity to shape a high-growth company’s commercial trajectory.
* A smart and thoughtful force multiplier, with strong judgment and the ability to reason clearly across legal, commercial, and operational dimensions.
* Detail-oriented operator who takes pride in precision, thoroughness, and getting the mechanics right.
* Low-ego collaborator who builds trust quickly with founders, executives, partners, and cross-functional teams.
* Proactive and resourceful, able to anticipate needs, identify gaps, and implement solutions without being asked.
* Curious and growth-oriented, excited to learn the nuances of AI-driven discovery and partnership structures.
* Comfortable with ambiguity, shifting priorities, and wearing multiple hats in a lean team. Can clearly articulate complex ideas across disciplines to internal and external stakeholders.

### **About Chai Discovery**

Chai Discovery builds frontier AI models to design molecules and transform how new cures are found. We are a craft-obsessed team setting out to re-architect drug discovery and save lives.

Chai was founded by leading researchers in the space and proven silicon valley operators, who previously co-invented protein language modeling, built state-of-the-art folding algorithms, and sold AI adopted by top-10 pharma companies. We have raised $230m from tier one investors, including OpenAI, Thrive, General Catalyst, Oak HC/FT, and Dimension. Our thesis is that small, elite teams out-iterate rivals.

### **Why Now?**

Deal volume and complexity continue to grow, especially post-launch of Chai-2. With many transactions in motion, Chai Discovery is seeking a VP, Business Development to serve as the operational engine behind high-stakes pharma partnership deals. This person will play a key role in shaping innovative transaction structures and novel IP frameworks for a revolutionary AI drug discovery platform.

### **About the role**

The VP, Business Development will partner with our founders to advance and secure strategic partnerships essential for Chai’s growth. As a strong operator with a growth-mindset, exceptional project management and problem-solving skills, and a passion for driving transactions to completion, this executive will play a key role in the evolution of the business at a critical juncture.

### **Key Responsibilities**

* Cultivate, manage, and push each deal forward. Lead negotiation of business points and translate the company’s business model and pricing strategy into clear, actionable deal structures. Serve as the operational lead managing all timelines, workflows, and cross-functional threads required to keep deals moving forward.
* Participate in the creation and management of “deal maps”, outlining each partnership’s path, key decision points, gatekeepers, and anticipated interpersonal, political, and business dynamics.
* Own the full contracting workflow, including drafting cycles, redlines, internal reviews, and coordination with external counsel, while maintaining momentum across all legal components of each deal, ensuring strategic partnerships progress smoothly from initial discussion through close.
* Help define and maintain the IP strategy supporting partnerships.
* Oversee contracts beyond partnerships, including CRO agreements and data-generation partners.

### **Ideal Experience and Qualifications**

* Execution-focused deal operator with legal grounding (JD preferred) and experience drafting, reviewing, and driving complex contracts forward.
* Background in biotech/pharma, or alternatively in startups/technology companies handling complex enterprise deals involving sensitive IP, software, AI models, or regulated data.
* Experience in a law firm supporting biotech, pharma, or regulated technology clients is also highly relevant.
* Demonstrated ability to run multi-step deals end-to-end, managing many simultaneous conversations, legal processes, and cross-functional threads.
* Detail-oriented and intellectually sharp, with strong judgment and the ability to spot risks, implications, and structural issues early.
* Hungry, thoughtful, and highly reliable, someone who founders and executives can trust with day-to-day deal mechanics.
* Track record of operating effectively in lean, founder-led, high-growth environments.

### **Personal Characteristics**

* Highly motivated by impact, responsibility, and the opportunity to shape a high-growth company’s commercial trajectory.
* A smart and thoughtful force multiplier, with strong judgment and the ability to reason clearly across legal, commercial, and operational dimensions.
* Detail-oriented operator who takes pride in precision, thoroughness, and getting the mechanics right.
* Low-ego collaborator who builds trust quickly with founders, executives, partners, and cross-functional teams.
* Proactive and resourceful, able to anticipate needs, identify gaps, and implement solutions without being asked.
* Curious and growth-oriented, excited to learn the nuances of AI-driven discovery and partnership structures.
* Comfortable with ambiguity, shifting priorities, and wearing multiple hats in a lean team. Can clearly articulate complex ideas across disciplines to internal and external stakeholders.

### **Location**

Chai Discovery is based in San Francisco, CA.

### **We offer**

* **Frontier technology:** work on the technologies that promises to fundamentally change how new therapeutics are created.
* **World-class people:** work with world-renowned leaders in the AI x Biology ecosystem.
* **Velocity and ownership:** we move incredibly fast and liberally distribute ownership, which means continuous learning and career growth opportunities are guaranteed.
* **Strong culture and mission:** we foster a supportive culture that is mission-driven and high-energy.
* **Highly competitive compensation:** we attract the best talent and compensate them accordingly.

[![Chai Discovery](https://storage.googleapis.com/simplify-imgs/companies/4b69743d-46e7-4986-9c4f-f6e6f6a52c6b/logo.png)](/c/Chai-Discovery)

Chai Discovery

[View](/c/Chai-Discovery)

[Website](https://www.chaidiscovery.com/?utm_source=Simplify)

[View Company Profile](/c/Chai-Discovery)

Chai Discovery specializes in developing advanced AI foundation models designed to predict and reprogram interactions between biochemical molecules, the essential components of life. The company operates in the biotechnology and pharmaceutical sectors, serving clients ranging from academic researchers to pharmaceutical companies. Chai Discovery's core product, Chai 1, is a state-of-the-art multimodal foundation model that excels in predicting molecular structures, including proteins, small molecules, DNA, RNA, and covalent modifications. The model is accessible for free via a web interface, making it available for both academic and commercial applications, particularly in drug discovery. The business model primarily revolves around providing this AI-driven platform to clients who can leverage it to accelerate their research and development processes. Revenue is generated through commercial licensing agreements and partnerships with pharmaceutical companies.

Company Size

11-50

Company Stage

Series B

Total Funding

$230M

Headquarters

San Francisco, California

Founded

2024

![Simplify Jobs](/cdn-cgi/image/width=3840/images/logos/logo-icon.svg)

### Simplify's Take

#### What believers are saying

* $130M Series B in December 2025 values Chai at $1.3B unicorn status.
* OpenAI backing and NVIDIA Slurm support accelerate biotech AI model training.
* Siemens-GlobalFoundries chips optimize Chai's molecular simulation performance.

#### What critics are saying

* AlphaFold 3 outperforms Chai 1 in protein-small molecule predictions now.
* Insilico Medicine's INS018\_055 reaches Phase 2, diverting pharma partnerships.
* Exscientia's EXS21546 enters Phase 1 trials, securing big pharma deals.

#### What makes Chai Discovery unique

* Chai 1 predicts structures of proteins, small molecules, DNA, RNA, and covalent modifications.
* Chai 2 achieves double-digit success in zero-shot de novo antibody design.
* Free web interface enables academic and commercial molecular reprogramming access.

Help us improve and share your feedback! Did you find this helpful?

YesNo

### Benefits

Health Insurance

Company Equity

Professional Development Budget

Wellness Program

### Growth & Insights and Company News

Growth & Insights

Headcount

### 6 month growth

↑ 7%

### 1 year growth

↑ 12%

### 2 year growth

↑ 21%

AutomationTools.ai

Jan 20th, 2026

[55 US AI Startups That Secured $100M+ in Funding in 2025](https://automationtools.ai/2026/01/20/55-us-ai-startups-that-secured-100m-in-funding-in-2025)

55 US AI startups that secured $100M+ in funding in 2025.
The AI industry began 2025 on a strong note, building on the momentum established in 2024, where 49 startups in the U.S. secured funding rounds exceeding $100 million. Notably, three companies attracted multiple mega-rounds, and seven achieved funding of $1 billion or more.
In 2025, although fewer companies surpassed the $1 billion threshold, there was a remarkable increase in the number of firms securing multiple rounds of financing - eight in total, including Anthropic, which raised two rounds exceeding $1 billion. Significant early signs for 2026 emerged when Elon Musk's xAI announced a staggering $20 billion Series E round, and Sam Altman's Merge Labs raised a $250 million seed round led by OpenAI.
Here are some highlights from the significant funding activity in 2025:
December highlights.
\* Mythic raised $125 million, enhancing their AI computing technology.
\* Chai Discovery secured $130 million to further develop AI models for biotech.
\* Fal gathered $140 million, tripling their valuation to over $4.5 billion.
\* Unconventional AI raised a significant $475 million seed round.
\* 7AI, specializing in AI for cybersecurity, raised $130 million.
November highlights.
\* Genspark joined the unicorn club with a $275 million Series B round.
\* Luma AI raised $900 million, positioning them at a $4 billion valuation.
\* Anysphere saw a record-setting $2.3 billion funding round.
October highlights.
\* Fireworks AI raised $250 million, while Uniphore collected $260 million in a Series F round.
\* Sierra, a customer service AI platform, received $350 million, valuing the company at over $10 billion.
September highlights.
\* Cognition AI raised $400 million, reaching a valuation of $10.2 billion.
\* Anthropic raised a massive $13 billion Series F funding round.
This funding landscape demonstrates the astonishing trajectory of AI startups, as they adapt and innovate across various sectors, from healthcare to media. The pace and scale of investment signal a robust future for AI, with diverse applications that are increasingly becoming central to numerous industries.
For more details, you can explore the original piece here.
Post navigation.

AI Cyber Media

Jan 19th, 2026

[AI Industry Continues to Surge with Multi-Billion Dollar Investments in 2025](https://www.aicybermedia.com.au/blogs/140)

AI industry continues to surge with multi-billion dollar investments in 2025.
The AI industry continued its growth trend into 2025, building on a strong 2024 where 49 startups raised at least $100 million. Significant funding rounds included Anthropic, which raised two rounds exceeding $1 billion, and Elon Musk's xAI, which announced a $20 billion Series E round. Key developments include:
\* Anthropic and other startups achieving 'mega-rounds,' reflecting increased multiple funding instances compared to 2024.
\* Sam Altman's Merge Labs securing a $250 million seed round, with OpenAI leading the investment.
\* Enthusiasm for AI continues as several companies, including Luma AI ($900 million) and Anysphere ($2.3 billion), achieved high valuations.
Recent notable investments by U.S. AI companies include:
\* In December, Mythic, with its power-efficient AI compute, raised $125 million, Chai Discovery announced a $130 million round, and Unconventional AI landed a $475 million seed round.
\* In November, Genspark closed a $275 million Series B round, and Luma AI secured $900 million.
\* Notably, OpenA

[... truncated ...]